400-921-8278
| Catalog_no | ADMC0445 |
| Product_name | Toceranib(SU 11654; PHA 291639) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 2000.00/5120.00/9200.00 |
| Specificity | Target: PDGFR. Fields: Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ. |
| Dilution | |
| Purification | >98% |
| Concentration | 靶点：PDGFR;IC50：No data |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | SU 11654; PHA 291639; SU11654; SU-11654; PHA-291639; PHA291639 |
| Observed_band | 396.457903 |
| Notes | Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
